Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer

NCT01875393 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: TOOKAD® Soluble

Sponsor

Steba Biotech S.A.